| Accumulated other comprehensive income reflected on the Consolidated Balance Sheets |
The following table reflects changes in accumulated other comprehensive income/(loss) by component as of June 28, 2025 and September 28, 2024: | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in thousands) | | Cumulative Foreign Currency Translation Adjustment | | Pension Plan Adjustments | | Gain / (Loss) on Derivative Instruments | | Total | | As of September 28, 2024 | | $ | (13,261) | | | $ | (1,682) | | | $ | 1,521 | | | $ | (13,422) | | | Other comprehensive loss before reclassifications | | (6,916) | | | (91) | | | (224) | | | (7,231) | | | Amount reclassified out of accumulated other comprehensive (loss)/income | | (815) | | | — | | | 132 | | | (683) | | | Tax effects | | 154 | | | — | | | — | | | 154 | | | Other comprehensive loss | | (7,577) | | | (91) | | | (92) | | | (7,760) | | | As of June 28, 2025 | | $ | (20,838) | | | $ | (1,773) | | | $ | 1,429 | | | $ | (21,182) | |
|
| Restricted stock and common stock granted |
The following table reflects Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock granted during the three and nine months ended June 28, 2025 and June 29, 2024: | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended | | Nine months ended | | (shares in thousands) | June 28, 2025 | | June 29, 2024 | | June 28, 2025 | | June 29, 2024 | | Time-based RSUs | 4 | | | 4 | | | 567 | | | 506 | | | Relative TSR PSUs | — | | | 1 | | | 128 | | | 232 | | | Growth PSUs | — | | | — | | | — | | | 49 | | | Common stock | 8 | | | 6 | | | 22 | | | 19 | | | Equity-based compensation in shares | 12 | | | 11 | | | 717 | | | 806 | |
|
| Equity-based compensation expense |
The following table reflects total equity-based compensation expense, which includes Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock, included in the Consolidated Condensed Statements of Operations during the three and nine months ended June 28, 2025 and June 29, 2024: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended | | Nine months ended | | | | | (in thousands) | June 28, 2025 | | June 29, 2024 | | June 28, 2025 | | June 29, 2024 | | | | | Cost of sales | $ | 376 | | | $ | 315 | | | $ | 1,146 | | | $ | 1,037 | | | | | | Selling, general and administrative | 4,527 | | | 4,300 | | | 13,186 | | | 14,083 | | | | | | Research and development | 2,189 | | | 1,748 | | | 6,394 | | | 5,332 | | | | | | Total equity-based compensation expense | $ | 7,092 | | | $ | 6,363 | | | $ | 20,726 | | | $ | 20,452 | | | | |
The following table reflects equity-based compensation expense, by type of award, for the three and nine months ended June 28, 2025 and June 29, 2024: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended | | Nine months ended | | | | | (in thousands) | June 28, 2025 | | June 29, 2024 | | June 28, 2025 | | June 29, 2024 | | | | | Time-based RSUs | $ | 5,003 | | | $ | 4,327 | | | $ | 15,369 | | | $ | 13,340 | | | | | | Relative TSR PSUs | 1,705 | | | 1,484 | | | 5,320 | | | 4,317 | | | | | | Growth PSUs | 113 | | | 237 | | | (863) | | | 1,850 | | | | | | | | | | | | | | | | | Common stock | 271 | | | 315 | | | 900 | | | 945 | | | | | | Total equity-based compensation expense | $ | 7,092 | | | $ | 6,363 | | | $ | 20,726 | | | $ | 20,452 | | | | |
|